Historical Perspective on Mitochondrial Medicine
Overview
Authors
Affiliations
In this review, we trace the origins and follow the development of mitochondrial medicine from the premolecular era (1962-1988) based on clinical clues, muscle morphology, and biochemistry into the molecular era that started in 1988 and is still advancing at a brisk pace. We have tried to stress conceptual advances, such as endosymbiosis, uniparental inheritance, intergenomic signaling and its defects, and mitochondrial dynamics. We hope that this historical review also provides an update on mitochondrial medicine, although we fully realize that the speed of progress in this area makes any such endeavor akin to writing on water.
Mitochondrial diseases: from molecular mechanisms to therapeutic advances.
Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X Signal Transduct Target Ther. 2025; 10(1):9.
PMID: 39788934 PMC: 11724432. DOI: 10.1038/s41392-024-02044-3.
Berti B, Verrigni D, Nasca A, Di Nottia M, Leone D, Torraco A Int J Mol Sci. 2024; 25(14).
PMID: 39063023 PMC: 11277250. DOI: 10.3390/ijms25147782.
Mitochondrial Ataxias: Molecular Classification and Clinical Heterogeneity.
Lopriore P, Ricciarini V, Siciliano G, Mancuso M, Montano V Neurol Int. 2022; 14(2):337-356.
PMID: 35466209 PMC: 9036286. DOI: 10.3390/neurolint14020028.
Applying genomic and transcriptomic advances to mitochondrial medicine.
Macken W, Vandrovcova J, Hanna M, Pitceathly R Nat Rev Neurol. 2021; 17(4):215-230.
PMID: 33623159 DOI: 10.1038/s41582-021-00455-2.
The Dimensions of Primary Mitochondrial Disorders.
Schlieben L, Prokisch H Front Cell Dev Biol. 2020; 8:600079.
PMID: 33324649 PMC: 7726223. DOI: 10.3389/fcell.2020.600079.